The Latest: EU regulator studies virus drug effect on kidney
|
October 2, 2020 11:03 AM
LONDON — The European Medicines Agency has started a safety review after some patients taking the coronavirus drug remdesivir reported serious kidney problems.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
